15YR企业会员
英文名称 | 中文名称 | CAS |
---|---|---|
H-Val-D-Pro-Pro-OH | H-VAL-D-PRO-PRO-OH | |
Human CMV Assemblin Protease Inhibitor | HUMAN CMV ASSEMBLIN PROTEASE INHIBITOR | 166603-46-9 |
Imperatoxin A | 欧前胡素A | 172451-37-5 |
H-Tyr-Tyr-Tyr-OH | L-酪氨酰-L-酪氨酰-L-酪氨酸 | 7390-78-5 |
IL-1b (178-207) (human) | LEU-LYS-GLU-LYS-ASN-LEU-TYR-LEU-SER-CYS-VAL-LEU-LYS-ASP-ASP-LYS-PRO-THR-LEU-GLN-LEU-GLU-SER-VAL-ASP-PRO-LYS-ASN-TYR-PRO | |
Insulin B (22-25) | INSULIN B (22-25) | 34367-73-2 |
H-Val-Phe-OH | H-VAL-PHE-OH | 3918-92-1 |
IELLQAR (8-branch MAPS) Selectin Binding Peptide;IELLQAR | ILE-GLU-LEU-LEU-GLN-ALA-ARG | |
H-Val-Lys-Lys-Arg-OH | H-VAL-LYS-LYS-ARG-OH | 286471-39-4 |
H-Val-Tyr-NH2 · HCl | H-VAL-TYR-NH2 · HCL | 126712-17-2 |
INSL 4 A Chain / Insulin-like 4 A Chain (Human) | SER-GLY-ARG-HIS-ARG-PHE-ASP-PRO-PHE-CYS-CYS(ACM)-GLU-VAL-ILE-CYS-ASP-ASP-GLY-THR-SER-VAL-LYS-LEU-CYS-THR | |
IL-1 Receptor Peptide (human) | IL-1 RECEPTOR PEPTIDE (HUMAN) | 141801-03-8 |
H-Val-Leu-Ser-Glu-Gly-OH | H-VAL-LEU-SER-GLU-GLY-OH | 83178-69-2 |
H-Val-Pro-Pro-OH | H-VAL-PRO-PRO-OH | 58872-39-2 |
H-Val-Ile-OH | H-VAL-ILE-OH | 20556-14-3 |
H-Val-β-Ala-OH | 缬氨酰-丙氨酸 | 27493-61-4 |
H-Val-Trp-Ile-OH | H-VAL-TRP-ILE-OH | |
Indolicidin;ILPWKWPWWPWRR-NH2 | 抗菌肽Indolicidin | 140896-21-5 |
H-Val-Gly-Gly-OH | H-VAL-GLY-GLY-OH | 21835-35-8 |
Influenza NP (482-489);SNEGSYFF | SER-ASN-GLU-GLY-SER-TYR-PHE-PHE | |
H-Val-Ala-Ala-Phe-OH | H-VAL-ALA-ALA-PHE-OH | 21957-32-4 |
H-Val-Gln-OH | H-VAL-GLN-OH | 42854-54-6 |
H-Val-Leu-Ser-OH | H-VAL-LEU-SER-OH | |
Dipeptide-2 | 二肽-2 | 24587-37-9 |
HY Peptide [246-254] | H-WMHHNMDLI-OH | |
Ile-Arg-Ile-Cys(Me)-Arg-Lys-Gly-NH2 | ILE-ARG-ILE-CYS(ME)-ARG-LYS-GLY-NH2 | |
H-Val-Val-Val-NH2 · HBr | H-VAL-VAL-VAL-NH2 · HBR | |
H-Val-Tyr-Pro-OH | H-VAL-TYR-PRO-OH | 68076-97-1 |
Influenza NP (50-57);SDYEGRLI | SER-ASP-TYR-GLU-GLY-ARG-LEU-ILE | |
Influenza NP (147-155);TYQRTRALV | THR-TYR-GLN-ARG-THR-ARG-ALA-LEU-VAL | 132326-72-8 |
H-Val-Gly-NH2 · HCl | H-VAL-GLY-NH2 · HCL | 98035-61-1 |
Insulin Receptor (1142-1153);TRDIYETDYYRK | THR-ARG-ASP-ILE-TYR-GLU-THR-ASP-TYR-TYR-ARG-LYS-NH2 | |
H-Val-Arg-OH | H-VAL-ARG-OH | 37682-75-0 |
H-Val-Gly-OH | H-VAL-GLY-OH | 686-43-1 |
H-Val-His-OH | H-VAL-HIS-OH | 13589-07-6 |
Hypertrehalosaemic Neuropeptide, Nauphoeta cinerea | HYPERTREHALOSAEMIC NEUROPEPTIDE (NAUPHOETA CINEREA) | 106018-36-4 |
V-T-C-G | H-VAL-THR-CYS-GLY-OH | 131204-46-1 |
H-Val-Met-OH | L-缬氨酰-L-蛋氨酸 | 14486-09-0 |
H-Val-Glu-OH | H-VAL-GLU-OH | 3062-07-5 |
H-Val-Val-Phe-OH | H-VAL-VAL-PHE-OH | 153247-47-3 |
Influenza HA (110-120);SFERFEIFPKE | SER-PHE-GLU-ARG-PHE-GLU-ILE-PHE-PRO-LYS-GLU | |
Insulin B (9-23) ??;SHLVEALYLVCGERG | NH2-SHLVEALYLVCGERG-OH | |
Influenza HA (529-537);IYATVAGSL | ILE-TYR-ALA-THR-VAL-ALA-GLY-SER-LEU | |
H-Val-Lys-OH | H-VAL-LYS-OH | |
H-Val-Val-OH | H-VAL-VAL-OH | 3918-94-3 |
Influenza HA (307-319);PKYVKQNTLKLAT | PRO-LYS-TYR-VAL-LYS-GLN-ASN-THR-LEU-LYS-LEU-ALA-THR | 528526-85-4 |
Human Parainfluenza Virus Type 3 Fusion Protein (454-488) (acetylated) | HUMAN PARAINFLUENZA VIRUS TYPE 3 FUSION PROTEIN (454-488) (ACETYLATED) | |
Influenza HA (204-212);LYQNVGTYV | LEU-TYR-GLN-ASN-VAL-GLY-THR-TYR-VAL | |
PKC Substrate 2;VRKRTLRRL | H-VAL-ARG-LYS-ARG-THR-LEU-ARG-ARG-LEU-OH | 105802-82-2 |
Insulin-Like Growth Factor I (24-41) | TYR-PHE-ASN-LYS-PRO-THR-GLY-TYR-GLY-SER-SER-SER-ARG-ARG-ALA-PRO-GLN-THR | 135861-49-3 |
Hypertrehalosaemic Neuropeptide, Heliothis zea;Pyr-LTFSSGWGN-NH2 | PYR-LEU-THR-PHE-SER-SER-GLY-TRP-GLY-ASN-NH2 | 117107-54-7 |
H-Val-Pro-OtBu · HCl | H-VAL-PRO-OTBU · HCL | 60108-51-2 |
H-Val-Lys-OH · HCl | H-VAL-LYS-OH · HCL | |
H-Tyr-Tyr-Phe-NH2 | H-TYR-TYR-PHE-NH2 | 117756-23-7 |
Hypocretin-1-Gly (Rat, Mouse) | LEU-GLY-VAL-ASP-ALA-GLN-PRO-LEU-PRO-ASP-CYS-CYS-ARG-GLN-LYS-THR-CYS-SER-CYS-ARG-LEU-TYR-GLU-LEU-LEU-HIS-GLY-ALA-GLY-ASN-HIS-ALA-ALA-GLY-ILE-LEU-THR-LEU-GLY | |
Immunstimulating Peptide, human | VAL-GLU-PRO-ILE-PRO-TYR: VEPIPY | |
IL-1b (208-240) (human) | LYS-LYS-LYS-MET-GLU-LYS-ARG-PHE-VAL-PHE-ASN-LYS-ILE-GLU-ILE-ASN-ASN-LYS-LEU-GLU-PHE-GLU-SER-ALA-GLN-PHE-PRO-ASN-TRP-TYR-ILE-SER-THR | |
H-Val-Phe-NH2 · HCl | H-VAL-PHE-NH2 · HCL | 129678-27-9 |
I-309 (human) | LYS-SER-MET-GLN-VAL-PRO-PHE-SER-ARG-CYS-CYS-PHE-SER-PHE-ALA-GLU-GLN-GLU-ILE-PRO-LEU-ARG-ALA-ILE-LEU-CYS-TYR-ARG-ASN-THR-SER-SER-ILE-CYS-SER-ASN-GLU-GLY-LEU-ILE-PHE-LYS-LEU-LYS-ARG-GLY-LYS-GLU-ALA-CYS-ALA-LEU-ASP-THR-VAL-GLY-TRP-VAL-GLN-ARG-HIS-ARG-LYS-MET | |
Hymenistatin I | HYMENISTATIN I | 1173938-18-5 |
Humanin, HN;MAPRGFSCLLLLTSEIDLPVKRRA | 护脑素(人体) | 330936-69-1 |
IDR-1 | IDR-1 | 940291-10-1 |
IFN-γ Antagonist | IFN-Γ ANTAGONIST | |
H-Tyr-Tyr-OH | H-TYR-TYR-OH | 1050-28-8 |
H-Val-Tyr-Val-OH | H-VAL-TYR-VAL-OH | 17355-22-5 |
Influenza HA (110-119);SFERFEIFPK | SER-PHE-GLU-ARG-PHE-GLU-ILE-PHE-PRO-LYS | 132031-50-6 |
H-Val-Val-Val-OH | H-VAL-VAL-VAL-OH | 28130-13-4 |
H-Tyr-Tyr-Tyr-OMe | H-TYR-TYR-TYR-OME | 53566-70-4 |
H-Val-Val-Lys-OH | H-Val-Val-Lys-OH | 73015-99-3 |
H-Val-Leu-OH · HCl | L-亮氨酸L-戊基盐酸盐(1:1) | 95977-55-2 |
Insulin Receptor (689-702) | INSULIN RECEPTOR (689-702) | |
Interleukin-6 (88-121), human | ILE-ILE-THR-GLY-LEU-LEU-GLU-PHE-GLU-VAL-TYR-LEU-GLU-TYR-LEU-GLN-ASN-ARG-PHE-GLU-SER-SER-GLU-GLU-GLN-ALA-ARG-ALA-VAL-GLN-MET-SER-THR-LYS | 145990-81-4 |
H-Val-Ile-His-Thr-EDANS | H-VAL-ILE-HIS-THR-EDANS | |
H-Val-Gly-Asp-Glu-OH | H-VAL-GLY-ASP-GLU-OH | 63141-66-2 |
H-Val-Val-Val-Val-OH | H-VAL-VAL-VAL-VAL-OH | 64577-64-6 |
H-Tyr-Tyr-NH2 · HCl | H-TYR-TYR-NH2 · HCL | |
Inactivation Gate Peptide | INACTIVATION GATE PEPTIDE | 156162-44-6 |
H-Val-Ala-pNA | H-VAL-ALA-PNA | 87810-63-7 |
Iberiotoxin | IBERIOTOXIN毒素肽 | 129203-60-7 |
Melanocyte Protein PMEL 17 (185-193) (human, bovine, mouse) | ILE-THR-ASP-GLN-VAL-PRO-PHE-SER-VAL: ITDQVPFSV | 162558-10-3 |
H-Val-Tyr-OH | H-VAL-TYR-OH | 3061-91-4 |
Influenza HA (518-526);IYSTVASSL | ILE-TYR-SER-THR-VAL-ALA-SER-SER-LEU | 186302-15-8 |
H-Tyr-Tyr-Phe-OH | H-TYR-TYR-PHE-OH | |
IFN-α Receptor Recognition Peptide 1 (IRRP1) | IFN-Α RECEPTOR RECOGNITION PEPTIDE 1 (IRRP1) | |
Influenza A M2 coat protein (22-46)??;SSDPLVVAASIIGILHLILWILDRL | SER-SER-ASP-PRO-LEU-VAL-VAL-ALA-ALA-SER-ILE-ILE-GLY-ILE-LEU-HIS-LEU-ILE-LEU-TRP-ILE-LEU-ASP-ARG-LEU | |
Hypercalcemia Malignancy Factor (7-34), amide, human;LLHDKGKSIQDLRRRFFLHHLIAEIHTA-NH2 | LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-ILE-ALA-GLU-ILE-HIS-THR-ALA-NH2 | 115695-30-2 |
Insulin-Like Growth Factor II (33-40) | SER-ARG-VAL-SER-ARG-ARG-SER-ARG | 103244-41-3 |
H-Val-His-Leu-Thr-Pro-OH | H-VAL-HIS-LEU-THR-PRO-OH | 93913-38-3 |
H-Val-Asn-OH | H-VAL-ASN-OH | 66170-00-1 |
H-Val-Ser-OH | H-VAL-SER-OH | 13588-94-8 |
H-Val-Asp-OH | H-VAL-ASP-OH | 20556-16-5 |
H-Val-Tyr-Ser-βNA | H-VAL-TYR-SER-ΒNA | 13989-68-9 |
IL-1β (163-171) (human) | IL-1Β (163-171) (HUMAN) | |
H-Val-Leu-Lys-pNA · 2 HCl | H-VAL-LEU-LYS-PNA · 2 HCL | |
H-Tyr-Val-OH | H-TYR-VAL-OH | 17355-09-8 |
H-Val-Pro-OH · HCl | H-VAL-PRO-OH · HCL | 105931-64-4 |
Influenza HA (210-219);TYVSVGTSTL | THR-TYR-VAL-SER-VAL-GLY-THR-SER-THR-LEU | |
Insulin-Like Growth [Tyr0] Factor II (33-40) | TYR-SER-ARG-VAL-SER-ARG-ARG-SER-ARG | |
IL-1a (223-250) (human) | PHE-PHE-TYR-GLU-THR-HIS-GLY-THR-LYS-ASN-TYR-PHE-THR-SER-VAL-ALA-HIS-PRO-ASN-LEU-PHE-ILE-ALA-THR-LYS-GLN-ASP-TYR | |
H-Val-Val-Gln-OH | H-VAL-VAL-GLN-OH | 212207-62-0 |
联系方式